Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Italy: Growing Private Sector, Limited Public Funding In Italy: Wegovy and Saxenda are both approved for obesity treatment Most people get these medicines through private doctors Public healthcare may cover these medicines in exceptional cases, but only for people with very severe obesity and serious health problems National rules are slowly changing, but public coverage is still limited and not consistent across the country Private costs in Italy: About 250 to 350 per month for Wegovy About 200 to 300 per month for Saxenda Who prescribes GLP-1s in Italy
Simethicone is not absorbed systemically and has no known clinically significant drug interactions, making it safe in essentially all patients including those on complex medication regimens
Combining the medication with healthy lifestyle changes, including dietary plans and regular exercise, is essential for achieving sustainable results
& Bancalari, E
A good rule of thumb is to move to a different area each week and avoid injecting into spots that feel sore, firm, or scarred
